Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $187.2 million.

  • Icu Medical's Operating Expenses fell 480.84% to $187.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $771.4 million, marking a year-over-year decrease of 59.17%. This contributed to the annual value of $781.8 million for FY2024, which is 903.29% up from last year.
  • Icu Medical's Operating Expenses amounted to $187.2 million in Q3 2025, which was down 480.84% from $197.5 million recorded in Q2 2025.
  • Icu Medical's 5-year Operating Expenses high stood at $211.0 million for Q1 2022, and its period low was $86.1 million during Q1 2021.
  • Over the past 5 years, Icu Medical's median Operating Expenses value was $186.9 million (recorded in 2022), while the average stood at $167.9 million.
  • As far as peak fluctuations go, Icu Medical's Operating Expenses soared by 14502.15% in 2022, and later crashed by 1380.48% in 2023.
  • Over the past 5 years, Icu Medical's Operating Expenses (Quarter) stood at $103.7 million in 2021, then skyrocketed by 68.97% to $175.2 million in 2022, then grew by 4.91% to $183.8 million in 2023, then grew by 3.16% to $189.6 million in 2024, then fell by 1.27% to $187.2 million in 2025.
  • Its Operating Expenses was $187.2 million in Q3 2025, compared to $197.5 million in Q2 2025 and $197.2 million in Q1 2025.